Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+31.0%
5Y CAGR+14.9%
Year-over-Year Change
Research and development spending
3Y CAGR
+31.0%/yr
vs +6.7%/yr prior
5Y CAGR
+14.9%/yr
Recent acceleration
Acceleration
+24.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $81.18M | +278.9% |
| 2024 | $21.43M | -12.7% |
| 2023 | $24.54M | -32.0% |
| 2022 | $36.08M | +12.4% |
| 2021 | $32.10M | -20.7% |
| 2020 | $40.50M | -27.6% |
| 2019 | $55.91M | +100.7% |
| 2018 | $27.86M | +3.6% |
| 2017 | $26.89M | +26.7% |
| 2016 | $21.22M | - |